Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Vinay Kumar Rathi, M.D.

Concepts

This page shows the publications Vinay Rathi has written about United States.
Connection Strength

0.941
  1. Assessment of FDA Approval for New High-risk Therapeutic Devices Not Meeting Pivotal Study Primary End Points, 2016-2020. JAMA Intern Med. 2021 10 01; 181(10):1409-1412.
    View in: PubMed
    Score: 0.033
  2. Medicare's New Device-Coverage Pathway - Breakthrough or Breakdown? N Engl J Med. 2021 Mar 25; 384(12):e43.
    View in: PubMed
    Score: 0.032
  3. Moving Toward Equitable Telemedicine in Otolaryngology-Head and Neck Surgery-Reply. JAMA Otolaryngol Head Neck Surg. 2021 02 01; 147(2):220.
    View in: PubMed
    Score: 0.031
  4. Physician Performance in the Medicare Merit-based Incentive Payment System. JAMA. 2021 01 19; 325(3):308.
    View in: PubMed
    Score: 0.031
  5. Medicare Reform of Hospital Payment for Inpatient Facial Plastic Procedures. Facial Plast Surg Aesthet Med. 2021 Jan-Feb; 23(1):2-4.
    View in: PubMed
    Score: 0.031
  6. Compensation Rates for Otolaryngologic Procedures Under the Medicare Physician Fee Schedule in 2018. Laryngoscope. 2021 06; 131(6):E1785-E1791.
    View in: PubMed
    Score: 0.031
  7. Clinical Evidence Supporting US Food and Drug Administration Clearance of Novel Therapeutic Devices via the De Novo Pathway Between 2011 and 2019. JAMA Intern Med. 2020 12 01; 180(12):1701-1703.
    View in: PubMed
    Score: 0.031
  8. Regulation of Over-the-Counter Hearing Aids - Deafening Silence from the FDA. N Engl J Med. 2020 Nov 19; 383(21):1997-2000.
    View in: PubMed
    Score: 0.031
  9. Incomplete Picture of Otolaryngologist Performance in the Merit-Based Incentive Payment System-Reply. JAMA Otolaryngol Head Neck Surg. 2020 11 01; 146(11):1087-1088.
    View in: PubMed
    Score: 0.031
  10. Price Transparency for COVID-19 Testing Among Top US Hospitals. J Gen Intern Med. 2021 01; 36(1):245-247.
    View in: PubMed
    Score: 0.030
  11. CARES Act Provider Relief Fund Aid to Otolaryngologists in Small Practices. Otolaryngol Head Neck Surg. 2021 03; 164(3):542-544.
    View in: PubMed
    Score: 0.030
  12. Postmarket Clinical Evidence for High-Risk Therapeutic Medical Devices Receiving Food and Drug Administration Premarket Approval in 2010 and 2011. JAMA Netw Open. 2020 08 03; 3(8):e2014496.
    View in: PubMed
    Score: 0.030
  13. Early experience with the FDA's Breakthrough Devices program. Nat Biotechnol. 2020 08; 38(8):933-938.
    View in: PubMed
    Score: 0.030
  14. Revaluation of Otolaryngologic Procedures With 10- and 90-Day Global Periods in the Medicare Physician Fee Schedule. Otolaryngol Head Neck Surg. 2020 Oct; 163(4):755-758.
    View in: PubMed
    Score: 0.030
  15. Getting Incentives Right in Payment Reform: Thinking Beyond Financial Risk. Ann Intern Med. 2020 03 17; 172(6):423-424.
    View in: PubMed
    Score: 0.029
  16. Modernizing the FDA's 510(k) Pathway. N Engl J Med. 2019 Nov 14; 381(20):1891-1893.
    View in: PubMed
    Score: 0.029
  17. Off-label Treatment in Otolaryngology-A Cautionary Tale. JAMA Otolaryngol Head Neck Surg. 2019 May 01; 145(5):399-400.
    View in: PubMed
    Score: 0.028
  18. The Centers for Medicare & Medicaid Services' Overhaul of Office-Visit Payments-What's the Bottom Line for Otolaryngology? JAMA Otolaryngol Head Neck Surg. 2019 Apr 01; 145(4):303-304.
    View in: PubMed
    Score: 0.028
  19. First-Year Report Cards From the Merit-Based Incentive Payment System (MIPS): What Will Be Learned and What Next? JAMA. 2019 Mar 26; 321(12):1157-1158.
    View in: PubMed
    Score: 0.028
  20. Device Safety. Otolaryngol Clin North Am. 2019 Feb; 52(1):103-114.
    View in: PubMed
    Score: 0.027
  21. The Merit-based Incentive Payment System (MIPS): A Primer for Otolaryngologists. Otolaryngol Head Neck Surg. 2018 09; 159(3):410-413.
    View in: PubMed
    Score: 0.026
  22. US Food and Drug Administration Clearance of Moderate-Risk Otolaryngologic Devices via the 510(k) Process, 1997-2016. Otolaryngol Head Neck Surg. 2017 10; 157(4):608-617.
    View in: PubMed
    Score: 0.025
  23. Industry Sponsorship of Research in Otolaryngology: An Examination of the Centers for Medicare & Medicaid Services Open Payments Database. JAMA Otolaryngol Head Neck Surg. 2017 08 01; 143(8):842-843.
    View in: PubMed
    Score: 0.025
  24. Clinical Evidence Supporting US Food and Drug Administration Approval of Otolaryngologic Prescription Drug Indications, 2005-2014. Otolaryngol Head Neck Surg. 2017 04; 156(4):683-692.
    View in: PubMed
    Score: 0.024
  25. Clinical Evidence Supporting US Food and Drug Administration Premarket Approval of High-Risk Otolaryngologic Devices, 2000-2014. Otolaryngol Head Neck Surg. 2017 02; 156(2):285-288.
    View in: PubMed
    Score: 0.024
  26. The US Food and Drug Administration 515 Program Initiative: Addressing the Evidence Gap for Widely Used, High-Risk Cardiovascular Devices? JAMA Cardiol. 2016 05 01; 1(2):117-8.
    View in: PubMed
    Score: 0.022
  27. Characteristics of Clinical Studies Conducted Over the Total Product Life Cycle of High-Risk Therapeutic Medical Devices Receiving FDA Premarket Approval in 2010 and 2011. JAMA. 2015 Aug 11; 314(6):604-12.
    View in: PubMed
    Score: 0.021
  28. Postmarket Modifications of High-Risk Therapeutic Devices in Otolaryngology Cleared by the US Food and Drug Administration. Otolaryngol Head Neck Surg. 2015 Sep; 153(3):400-8.
    View in: PubMed
    Score: 0.021
  29. Industry ties in otolaryngology: initial insights from the physician payment sunshine act. Otolaryngol Head Neck Surg. 2015 Jun; 152(6):993-9.
    View in: PubMed
    Score: 0.021
  30. Otolaryngologists Trail Other Specialties in Industry Payments From Dermal Filler Companies. Laryngoscope. 2022 02; 132(2):301-306.
    View in: PubMed
    Score: 0.008
  31. Graduate Medical Education in Otolaryngology: Making Dollars and Sense of Reform. Otolaryngol Head Neck Surg. 2021 12; 165(6):762-764.
    View in: PubMed
    Score: 0.008
  32. Markup on Services Provided to Medicare Beneficiaries by Otolaryngologists in 2017: Implications for Surprise Billing. Otolaryngol Head Neck Surg. 2021 11; 165(5):662-666.
    View in: PubMed
    Score: 0.008
  33. Telemedicine Services Provided to Medicare Beneficiaries by Otolaryngologists Between 2010 and 2018. JAMA Otolaryngol Head Neck Surg. 2020 Sep 01; 146(9):816-821.
    View in: PubMed
    Score: 0.008
  34. Assessment of Gender Differences in Clinical Productivity and Medicare Payments Among Otolaryngologists in 2017. JAMA Otolaryngol Head Neck Surg. 2020 09 01; 146(9):1-10.
    View in: PubMed
    Score: 0.008
  35. Otolaryngologist Performance in the Merit-Based Incentive Payment System in 2017. JAMA Otolaryngol Head Neck Surg. 2020 07 01; 146(7):639-646.
    View in: PubMed
    Score: 0.008
  36. CMS Adoption of Prior Authorization Requirements-Implications for Facial Plastic Surgery. JAMA Otolaryngol Head Neck Surg. 2020 05 01; 146(5):397-398.
    View in: PubMed
    Score: 0.007
  37. Trends in Ambulatory Surgery Center Utilization for Otolaryngologic Procedures among Medicare Beneficiaries, 2010-2017. Otolaryngol Head Neck Surg. 2020 Jun; 162(6):873-880.
    View in: PubMed
    Score: 0.007
  38. State-Sponsored Price Transparency Initiatives for Otolaryngologic Procedures in 2019. JAMA Otolaryngol Head Neck Surg. 2020 04 01; 146(4):378-380.
    View in: PubMed
    Score: 0.007
  39. Implications of Private Equity Acquisition of Otolaryngology Physician Practices. JAMA Otolaryngol Head Neck Surg. 2020 02 01; 146(2):97-98.
    View in: PubMed
    Score: 0.007
  40. Financial Implications of Site-Neutral Payments for Clinic Visits in Otolaryngology. JAMA Otolaryngol Head Neck Surg. 2020 01 01; 146(1):78-79.
    View in: PubMed
    Score: 0.007
  41. Female Authorship of Opinion Pieces in Leading Otolaryngology Journals between 2013 and 2018. Otolaryngol Head Neck Surg. 2020 01; 162(1):35-37.
    View in: PubMed
    Score: 0.007
  42. Getting More Savings from ACOs - Can the Pace Be Pushed? N Engl J Med. 2019 Jun 06; 380(23):2190-2192.
    View in: PubMed
    Score: 0.007
  43. Use of Corticosteroid-Eluting Sinus Stents Between 2012 and 2017. JAMA Otolaryngol Head Neck Surg. 2019 Jan 01; 145(1):90-91.
    View in: PubMed
    Score: 0.007
  44. The role of industry influence in sinus balloon dilation: Trends over time. Laryngoscope. 2018 07; 128(7):1540-1545.
    View in: PubMed
    Score: 0.006
  45. Incremental Revisions across the Life Span of Ophthalmic Devices after Initial Food and Drug Administration Premarket Approval, 1979-2015. Ophthalmology. 2017 08; 124(8):1237-1246.
    View in: PubMed
    Score: 0.006
  46. Publication of Clinical Studies Supporting FDA Premarket Approval for High-Risk Cardiovascular Devices Between 2011 and 2013: A Cross-sectional Study. JAMA Intern Med. 2016 Apr; 176(4):551-2.
    View in: PubMed
    Score: 0.006
  47. How do Orthopaedic Devices Change After Their Initial FDA Premarket Approval? Clin Orthop Relat Res. 2016 Apr; 474(4):1053-68.
    View in: PubMed
    Score: 0.005
  48. Orthopaedic Surgeons Receive the Most Industry Payments to Physicians but Large Disparities are Seen in Sunshine Act Data. Clin Orthop Relat Res. 2015 Oct; 473(10):3297-306.
    View in: PubMed
    Score: 0.005
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.

Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.